Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Messina

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 18, 2026
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in ItalyPiero Barbanti, Cristina Tassorelli, Fabrizio Vernieri, et al.
Frontiers in Human Neuroscience|May 7, 2021
Pathophysiological Bases of Comorbidity in MigraineClaudia Altamura, Ilenia Corbelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|November 1, 2022
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patientsPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Journal of Neurology|June 28, 2022
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experienceClaudia Altamura, Nicoletta Brunelli, Marilena Marcosano, et al.
The Journal of Headache and Pain|March 2, 2026
Hallmarks of headache disorders: part 5 - secondary headachesDavid García-Azorín, Alba Perez-de-la-Parte, Claudio Tana, et al.
The Journal of Headache and Pain|October 2, 2025
Application of machine learning in migraine classification: a call for study design standardization and global collaborationIgor Petrušić, Roberta Messina, Lanfranco Pellesi, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Neurology and Therapy|June 9, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III StudyPiero Barbanti, Cinzia Aurilia, Massimo Filippi, et al.
The Journal of Headache and Pain|December 24, 2025
Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease StudyAlberto Raggi, Matteo Castaldo, Chia-Chun Chiang, et al.
Journal of Neurology|May 7, 2025
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II)Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 18, 2026
Building bridges in migraine management: consensus pathways on best practices across primary and specialist care in ItalyPiero Barbanti, Cristina Tassorelli, Fabrizio Vernieri, et al.
Frontiers in Human Neuroscience|May 7, 2021
Pathophysiological Bases of Comorbidity in MigraineClaudia Altamura, Ilenia Corbelli, Marina de Tommaso, et al.
The Journal of Headache and Pain|November 1, 2022
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patientsPiero Barbanti, Gabriella Egeo, Cinzia Aurilia, et al.
Journal of Neurology|June 28, 2022
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experienceClaudia Altamura, Nicoletta Brunelli, Marilena Marcosano, et al.
The Journal of Headache and Pain|March 2, 2026
Hallmarks of headache disorders: part 5 - secondary headachesDavid García-Azorín, Alba Perez-de-la-Parte, Claudio Tana, et al.
The Journal of Headache and Pain|October 2, 2025
Application of machine learning in migraine classification: a call for study design standardization and global collaborationIgor Petrušić, Roberta Messina, Lanfranco Pellesi, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Neurology and Therapy|June 9, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III StudyPiero Barbanti, Cinzia Aurilia, Massimo Filippi, et al.
The Journal of Headache and Pain|December 24, 2025
Risk factors associated to disability in primary headaches: a systematic review to inform future iterations of the Global Burden of Disease StudyAlberto Raggi, Matteo Castaldo, Chia-Chun Chiang, et al.
Journal of Neurology|May 7, 2025
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II)Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Pageof 8